Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04051294
Other study ID # 2014707
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 3, 2019
Est. completion date September 30, 2022

Study information

Verified date September 2023
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.


Description:

Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp & Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market. As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study. This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm. Arms (at least 5 subjects in each arm, minimum total=20 subjects) 1. Intervention group 1: commercial kombucha: drink 8oz kombucha 2. Intervention group 2: brewed kombucha: drink 8oz kombucha 3. Control group: drink 8oz tea (the same type as used to brew the kombucha) 4. Control group 2: drink 8oz tap water


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date September 30, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: - Men or women ages 30-65 years old - English-speaking - Have transportation to campus - Overweight (BMI >= 25 kg/m2) or obese (BMI >=30 kg/m2) Exclusion Criteria: - Currently use any type of nicotine product - A diagnosis of any of the following: - Diabetes (type 1 or 2) - Cancer - COPD - Chronic alcoholism - Peripheral vascular disease - Autoimmune disease - Chronic kidney disease - Pregnant or breastfeeding - Prescribed medication for insulin, glucose-lowering drugs, or steroids, such as prednisone - Have routinely taken prebiotic or probiotic supplements in the past 3 months - Have routinely consumed any of the following more than one time per week in the past month: kombucha, kefir, yogurt, kimchi, cottage cheese, raw apple cider vinegar (with the "mother"), sauerkraut, kvass.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Commercial kombucha tea
Commercially-available kombucha tea.
Brewed kombucha tea
Kombucha tea brewed
Other:
Control: Tea
Tea brewed in our lab.
Control: Water
Tap water

Locations

Country Name City State
United States University of Missouri Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting blood glucose level Blood drawn following a 10-12 hour fast. Baseline
Primary Fasting insulin level. Blood drawn following a 10-12 hour fast. Baseline
Primary Blood glucose level Oral glucose tolerance test 3 hour
Primary Insulin level Oral glucose tolerance test 3 hour
Secondary Blood pressure Baseline
See also
  Status Clinical Trial Phase
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Active, not recruiting NCT05618756 - CBD, Nutrient Metabolism and Energy Intake N/A
Completed NCT04791787 - Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes N/A
Not yet recruiting NCT05910840 - Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care N/A
Completed NCT06095622 - Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels N/A
Completed NCT05719675 - Healthcare Intervention Program on Treatment Adherence in People With Newly Diagnosed Type 2 Diabetes Mellitus. N/A
Recruiting NCT04201600 - Glucose Variability and Cognition in Prediabetes
Active, not recruiting NCT03337828 - Effect of Two Alcohol-free Beers With Different Carbohydrates Composition on Lipids and Glucose Metabolism N/A
Terminated NCT03191201 - A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis. Phase 4
Suspended NCT03566511 - Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Phase 2
Not yet recruiting NCT05764200 - Acute Microbial Switch N/A
Terminated NCT04938388 - Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care Phase 4
Recruiting NCT04227769 - IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes Phase 2
Completed NCT05581043 - Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes N/A
Recruiting NCT06334172 - The Role of Oxytocin in Regulating Blood Glucose N/A
Completed NCT03671161 - Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients N/A
Active, not recruiting NCT05176197 - Effects of Almonds on Glycemia in Adults With Elevated Hemoglobin A1c Concentrations N/A
Recruiting NCT06260254 - Effects of Railway Vibration on Sleep and Disease N/A
Recruiting NCT05090488 - Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health Care N/A